I-sodium oxybate iyisithako esisebenzayo esixhumeni se-Xyrem, esiye safundiswa nge- fibromyalgia (i-FMS) futhi ngezinye izikhathi sisetshenzisiwe ngaphandle kwelebuli ye-FMS nesifo esingapheliyo sokukhathala ( ME / CFS ).
Lesi sidakamizwa sinomthelela wokulutha umlutha nokuhlukunyezwa, ngakho-ke kubhekwa njengezinto ezilawulwa yiSheduli III. Lokhu kusho ukuthi kutholakala kuphela kubantu abahlangabezana nezidingo ezifanele ezifanelekile, kanti odokotela kudingeka baqaphe ukusetshenziswa kwawo eduze.
I-sodium oxbate iyindlela ye-gamma-hydroxybutyrate (GHB), eyaziwa nangokuthi "idakamizwa yokudlwengula idethi."
Okukwenzayo
I-sodium oxbate iyinkimbinkimbi yokucindezeleka yesimiso esicabanga ukuthi ikusize ukuba uthole isigaba esijulile sesigaba sesithathu nesigaba 4 sokulala. Okwamanje ivunyiwe e-US ngokunciphisa ubuthongo obusuku lwe-day kanye ne-cataplexy (ukulahlekelwa okungazelelwe kwamandla emisipha) kubantu abanezinkinga ze-narcolepsy.
Ubuthongo obunzima bukholelwa ukuthi aluphelelwe amandla ku-FMS naku-ME / CFS, okuholela ekuleleleni okungenakuphumula .
I-Fibromyalgia ne-Chronic Fatigue Syndrome
I-FDA ngo-2010 yenqabe ukuxilongwa kwe-sodium njengokwelashwa hhayi ngenxa yokuthi ayisebenzi, kodwa ngoba le nhlangano yayikhathazekile ngemiphumela yomphakathi yokwenza izidakamizwa eziyingozi zingatholakala kubantu abayizigidi.
Ukuhlolwa kwemitholampilo ku-FMS kuye kwabonisa ukuthi umuthi ungathuthukisa kakhulu izinga lokulala futhi unciphise ubuhlungu. Isifundo se-2013 (Spaeth) siphetha ngokuthi sinephrofayili yokuphepha yesikhathi eside.
Ucwaningo lwango-2010 (iSpitzer) luphakamisile ukuthi lungasebenza eM ME / CFS, kepha lokhu kwakuwukuqala ukuhlolwa kwalesi sidakamizwa nge-ME / CFS.
Isilinganiso
I-sodium oxybate ithathwa ngendlela ewuketshezi, ixubene namanzi. Isibalo esivamile sokuqala kweziguli ezinezinkinga eziphuthumayo yi-4.5 amagremu ngobusuku, zihlukaniswe ngezilinganiso ezimbili ezilinganayo ebusuku. Abantu bavame ukusebenza kuze kufike ku-6-9 amagremu ebusuku, namanje ku-2 amanani alinganayo.
Ngokuvamile, iziguli zeluleka ukuba zilungiselele kokubili amanani bese uzibeka ebusweni bokulala, bese uthatha owokuqala ngenkathi uhlezi embhedeni. Ungadinga iwashi le-alamu ukuvusa wena okwesibili. Lesi sidakamizwa sisebenza ngokushesha, ngakho kufanele uhlale embhedeni uma usuthathe.
Okuqhamuka uma udla imishanguzo
Yeka ukusebenzisa i-oxybate ye-sodium futhi uthole usizo lwezokwelapha ngokushesha uma unezimpawu zokuphendula okweqile, njenge:
- Ukuphefumula okunzima
- I-Hives
- Ukuvuvukala kobuso, izindebe, ulimi noma umphimbo
Yeka ukusebenzisa i-oxybate ye-sodium bese ubiza udokotela wakho ngokushesha uma unemiphumela emibi kakhulu, efaka:
- Ama-hallucinations
- Ukudideka okukhulu
- Ukuphefumula okungajulile
- Ukulala
- Ukuvuka kudidekile ebusuku
Ezinye imiphumela emibi ingase ibe yingozi kakhulu, kubandakanya:
- Ukufutheka
- I-paranoia
- Izinkinga zokulawula isisu noma isisindo
- Ukucindezeleka
- Ukudabuka noma ukuhlanza
- Ukulahlekelwa kwesifiso
- Iphutha le-Runny noma ukuxubaniswa kwe-nasal nokuphuza komphimbo
- Ubumbulu noma ukubetha
- Izidlova
- Umbono ophundlekile
Kungenzeka ukuthi ube nemiphumela emibi engabhalwanga lapha. Qiniseka ukuxoxa ngemiphumela emibi nodokotela wakho.
Ukuthola i-Oxybate ye-sodium
Odokotela bangakwazi ukubeka i-sodium oxbate off-ilebula uma bekhetha. Nokho, ngenxa yezingozi, akulula ukuthola i-oxybate ye-sodium.
Ukuze uzithole, udokotela wakho kufanele akubhalise ohlelweni olukhethekile.
Imithi yesiguli iya lapho ekhemisi kuphela e-US evunyelwe ukuyigcwalisa, futhi ikhemisi lihambisa imithi kuwe.
Uma ufuna ukuzama i-oxybate ye-sodium, khuluma nodokotela wakho. Nokho, khumbula ukuthi abanye odokotela bangase bangakhululekile ukuyibeka.
Imithombo:
I-NIH Publication CHA. 04-5326.
June 2007, Ukuphathwa Kwezokudla Nezidakamizwa zase-US, "Ukuphila ne-Fibromyalgia" .
URussell IJ, et al. Ubuhlungu. 2011 Meyi; 152 (5): 1007-17. I-sodium oxbate iyanciphisa ubuhlungu, ukukhathala, nokuphazamiseka kokulala futhi kuthuthukise ukusebenza ku-fibromyalgia: imiphumela yocwaningo olulawulwa nge-week-week, randomized, double-blind, blind-blind.
Spaeth M, et al. Izikhangiso zezifo ze-rheumatic. 2012 Jun; 71 (6): 935-42. Ukwelashwa kwe-sodium oxbate kunikeza ukuthuthukiswa okuhlukahlukene kwe-fibromyalgia: imiphumela yesigaba samazwe angama-3 esilingo.
Spaeth M, et al. Ucwaningo lwe-arthritis kanye nokwelapha. 2013 Nov 11; 15 (6): R185. Ukubekezelela isikhathi eside nokugcinwa kwempendulo yokwelapha kwi-sodium oxbate ekuhloleni okuvuliwe kwelebula ezigulini ezine-fibromyalgia.
I-Spitzer AR, umkhuba we-Broadman M. Pain. 2010 Jan-Feb; 10 (1): 54-9. Ukwelashwa kwe-narcoleptiform yokulala ukugula ekuguleni okungapheli kwesifo kanye ne-fibromyalgia ne-sodium oxbate.
Umbono ka-Staud R. Umhloli nge-pharmacotherapy. 2011 Aug; 12 (11): 1789-98. I-sodium oxybate yokwelashwa kwe-fibromyalgia.
Swick TJ. Ukuthuthukiswa kokwelashwa kwezifo ze-musculoskeletal. 2011 Aug; 3 (4): 167-78. I-sodium oxbate: okukhethwa kukho okusha kwemithi yokwelashwa kwe-fibromyalgia syndrome.